Company: DMAAR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076681
Chunk: 92

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 92
---
 the Sarbanes-Oxley Act of 2002.
  
    101.CAL
     
    XBRL Taxonomy Extension Calculation Linkbase Document
  
    101.SCH
     
    XBRL Taxonomy Extension Schema Document
  
    101.DEF
     
    XBRL Taxonomy Extension Definition Linkbase Document
  
    101.LAB
     
    XBRL Taxonomy Extension Labels Linkbase Document
  
    101.PRE
     
    XBRL Taxonomy Extension Presentation Linkbase Document
  
    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*Furnished
herewith

25

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

    Date: August 14, 2025
    DRUGS MADE IN AMERICA ACQUISITION CORP.

    By:
    /s/ Lynn Stockwell

    Name: 
    Lynn Stockwell

    Title:
    Chief Executive Officer

    (Principal Executive Officer)

    By:
    /s/ Glenn Worman

    Name:
    Glenn Worman

    Title:
    Chief Financial Officer

    (Principal Financial and Accounting Officer)

26

http://fasb.org/srt/2025#ChiefExecutiveOfficerMember
0002028614
false
Q2
--12-31

    0002028614

    2025-01-01
    2025-06-30

    0002028614
    
      dmaau:UnitsMember

    2025-01-01
    2025-06-30

    0002028614
    
      us-gaap:CommonStockMember

    2025-01-01
    2025-06-30

    0002028614
    
      dmaau:RightMember

    2025-01-01
    2025-06-30

    0002028614

    2025-08-14

    0002028614

    2025-06-30

    0002028614

    2024-12-31

    0002028614
    
      us-gaap:RelatedPartyMember

    2025-06-